Skip to content

Clinical Curative Effect and safe Research on treatment of hemorrhagic stroke with stage acupuncture

Clinical and basic Research of Curative Effect and safe on treatment of hemorrhagic stroke with stage acupuncture

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000225
Enrollment
Unknown
Registered
2008-12-03
Start date
2008-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral hemorrhage

Interventions

Group A:Including acute stage patients only and will be treated by routine western medicine
Group B:Including acute stage patients will be treated by acupuncture on the base of routine western medicine
Group C:Include convalescence stage patients and to be treated by acupuncture
Group D:Include convalescence stage patients and to be treated by rahabilitation

Sponsors

Yueyang integrated traditional Chinese and Western medicine hospital affiliated by Shanghai University of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. according to Diagnostic Criteria of Cerebral hemorrhage by western medicine, proved by head CT; 2. according to Diagnostic Criteria of Apoplectic disease by TCM; 3. patients with acute phase (apoplexy involving both collateral and meridian=18; 6. attacked by stroke 1 or 2 times(almostly recovered from the first time); 7. patients with acute phase complied with acupuncture treatment of acute cerebral hemorrhage indication (State Administration of Traditional Chinese Medicine to promote the project of the National Standards); 8. Informed and Consent.

Exclusion criteria

Exclusion criteria: 1. Confirmed by CT, non-cerebral hemorrhage stroke patients; 2. Craniotomy in patients with cerebral hemorrhage; 3. Subarachnoid hemorrhage, bleeding of the brain stem or cerebellum of patients; 4. women in pregnancy or lactation period; 5. combined with severe primary diseases in heart, liver, kidney, Hemopoietic System etc. Psychotic patie; 6. patients with acute phase complied with acupuncture treatment of acute cerebral hemorrhage contraindication (State Administration of Traditional Chinese Medicine of the National Project to promote the standard); 7. patients who not meet the including criteria, not accept regular treatment, or take other drugs, or incomplete information to impact on the results to determine efficacy or safety.

Design outcomes

Primary

MeasureTime frame
Neurological deficits scores;Mortality;Total function assessmen;

Secondary

MeasureTime frame
Ability of daily life;Motive function;

Countries

China

Contacts

Public ContactDong Guirong
dongguirong@tom.com+86 0 13162675069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026